It's just clarifying why the trials of AS at King Abdul Aziz University in Jeddah were cancelled last week -- which we already heard about. It seems the new company(https://alhidaya.com.sa/medical/) in SA is now working with the KSA FDA toward regulatory approval for using AS in SA... IMO, I would say this is good news.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.